No contemporary unifying framework has been provided for the study of non-ordinary states
of consciousness (NSCs) despite increased interest in hypnosis, meditation, and …

Objective Reports have indicated possible uses of ayahuasca for the treatment of conditions
including depression, addictions, post‐traumatic stress disorder, anxiety and specific …

The use of low sub-perceptual doses of psychedelics (“microdosing”) has gained popularity
in recent years. Although anecdotal reports claim multiple benefits associated with this …

The potent hallucinogen N, N-dimethyltryptamine (DMT) has garnered significant interest in
recent years due to its profound effects on consciousness and its therapeutic …

Introduction: N, N-dimethyltryptamine (DMT) is an endogenous serotonergic psychedelic
capable of producing radical shifts in conscious experience. Increasing trends in its use, as …

Background Psilocybin is a serotonergic psychedelic drug under assessment as a potential
therapy for treatment-resistant and major depression. Heterogeneous treatment responses …

Ayahuasca is a blend of Amazonian plants that has been used for traditional medicine by
the inhabitants of this region for hundreds of years. Furthermore, this plant has been …

Psychedelic drugs such as psilocybin and ketamine are returning to clinical research and
intervention across several disorders including the treatment of depression. This chapter …

There is a growing interest in the medical use of psychedelic substances, as preliminary
studies using them for psychiatric disorders have shown positive results. In particular, one of …

Psychedelics are attractive potential therapeutic agents for treatment resistant depression
due to their rapid and sustained effects. These effects have been largely attributed to …